West Pharmaceutical Services, Inc.

WST

Market Cap$26.84B

Close$

Compare West Pharmaceutical Services

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
West Pharmaceutical Services, Inc.	47.2	0.21%	21%	9.2	0.1
Market Avg	58.2	1.29%	31%	-	1
Healthcare Avg	64	1.3%	15%	-	0.9

$536.00

Target Price by Analysts

45.5% upsideWest Pharmaceutical Services Target Price Details

$162.41

Current Fair Value

55.9% downside

Overvalued by 55.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$26.84 Billion
Enterprise Value	$26.44 Billion
Dividend Yield	$0.7895 (0.21%)
Earnings per Share	$7.59
Beta	1.09
Outstanding Shares	72,843,157
Avg 30 Day Volume	444,152

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	47.2
PEG	-267.5
Price to Sales	9.21
Price to Book Ratio	10.23
Enterprise Value to Revenue	9.03
Enterprise Value to EBIT	38.81
Enterprise Value to Net Income	46
Total Debt to Enterprise	0.01
Debt to Equity	0.08

Revenue Sources

No data

ESG Score

No data

About West Pharmaceutical Services, Inc.

CEO: Eric Green